Magazine
Sign up for your free subscription and keep up-to-date.
Upcoming Events
Newsletters
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
News
|
Thermo Fisher Scientific's Antaris FT-NIR platform chosen by Abiogen Pharma to reduce analysis time Thermo Fisher Scientific Inc. announces that Abiogen Pharma S.p.A, a leading pharmaceutical manufacturer, headquartered in Pisa, Italy, has chosen the Thermo Scientific Antaris FT-NIR analytical system to perform raw materials characterization in its manufacturing facilities.
|
|
Symyx appoints Symyx Tools president Symyx Technologies, Inc. appoints Gerard Abraham as president of Symyx Tools, which automates and accelerates experimentation through modular systems and integrated high-throughput workflows. Abraham joins Timothy Campbell, president of Symyx Software, and Richard Boehner, head of Symyx Collaborations, in leading the companys three key business units.
|
|
TRLabs scholarship value to double TRLabs has increased its student scholarship values by 50%, effective Sept. 1, 2007.
|
|
Newfoundland family part of study that identifies pain gene Genetic work carried out at Memorial University in Newfoundland has contributed to the identification of the gene mutation responsible for a rare condition known as congenital indifference to pain (CIP).
|
|
Aspectrics to collaborate with Thermo Fisher Scientific Aspectrics, Inc., the innovator of Encoded Photometric Infrared (EP-IR) analyzers has entered into an exclusive agreement with Thermo Fisher Scientific to integrate Thermo Scientific GRAMS spectroscopy software with Aspectrics' groundbreaking Encoded Photometric Near Infrared (EP-NIR) process analyzers.
|
|
German-Based CSB-System International selects Kitchener for Canadian expansion Canada's Technology Triangle in the Waterloo Region has a new addition to its family.
|
|
Kodak receives Health Canada approval of its digital mammography system Eastman Kodak Company has obtained Health Canada approval for its computed radiography (CR) system for mammography. Health Canada's decision opens the door for Kodak to immediately begin selling the system in Canada.
|
|
Ondine's Periowave effective as treatment for oral diseases A recent in vitro study conducted by Ondine Biopharma may prove useful in the future prevention and treatment of oral and dental diseases.
|
|
Provincial optical research network launched Members of Newfoundland and Labrador's first optical research network have officially launched the ACORN-NL network.
|
|
NSERC opens new pacific regional office in Vancouver The Honourable Maxime Bernier, Minister of Industry and Suzanne Fortier, president of the Natural Sciences and Engineering Research Council of Canada (NSERC) were on hand for the opening of a new NSERC regional office based in Vancouver.
|
|
McMaster Lab to Expand RFID Research McMaster University will house a new radio frequency identification (RFID) research and development laboratory.
|
|
MTS Allstream Joins ICT Consortium MTS Allstream has joined TRLabs, an ICT industry-driven research and development consortium that includes 42 Canadian companies.
|
|
BioMS Medical launches multiple sclerosis trial BioMS Medical Corp. has enrolled its first patients in a placebo controlled, multi-centre Phase II clinical trial of MBP8298 for the treatment of relapsing remitting multiple sclerosis (RRMS).
|
|
Davos Forum Recognizes Potential of Amorfix Treatments The World Economic Forum will recognize Amorfix Life Sciences Ltd. as a technology pioneer when its corporate and political members gather in Davos, Switzerland this month (January) for their annual meeting.
|
|
Victhom prepares for investigational testing Victhom Human Bionics Inc. is waiting on approval from the Research Ethics Board to begin investigational testing of its Neuro-stepTM system.
|
|
CFI invests $422 million in Canadian research The Canada Foundation for Innovation, federally mandated to strengthen research capacity, made a $422 million investment in new research infrastructure in November with the announcement of its Leading Edge and New Initiatives funds.
|
|
Thermo Funds Toronto Program To Research Transplant Rejection Thermo Electron Corp. has signed a research and development agreement with the Research in Immune Tolerance in Transplantation (RITT) program to be conducted in its Industrial BioDevelopment Laboratory at the Toronto General Hospital.
|
|
BioMS Raises $20 Million for Research BioMS Medical Corp. raised $20.9 million Cdn following the private placement of over 6.1 million units at a price per unit of $3.41.
|
|
Consortium to Attract Clinical Research to the Rock Three companies from St. John's, Nfld have combined forces to offer comprehensive clinical trial consulting, operations and management services to pharmaceutical and biotechnology companies conducting trials in the province.
|
|
Victoria team to assess proteomics technologies The US National Cancer Institute awarded a University of Victoria research team $4 million over the next five years to develop a new technology for the identification of molecules critical to the early detection of breast cancer.
|
|
|
|
Amorfix Teams Up with National Research Council Amorfix Life Sciences Ltd. announces that in addition to its own investment, the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) will share in the research and development of the company's proposed diagnostic test for Alzheimer's disease.
|
|
Chromos Molecular Systems Inc. Appoints David Barr To Board Of Directors David Barr has been appointed to the board of directors of Chromos Molecular Systems Inc.
|
|
Benoit Côte Steps Down From Board Of Victhom Human Bionics Benoit Côte stepped down from the board of directors of Victhom Human Bionics in November.
|
|
Tony Wright Appointed Director Of Sales For Photonic Products Ltd. Tony Wright has been appointed director of sales for Photonic Products Ltd.
|
|
Amorfix Life Sciences Has Appointed Dr. Hans Black To Board Of Directors Dr. Hans Black has been appointed to the board of directors of Toronto, Ont.-based Amorfix Life Sciences.
|
|
Roman L. Zastawny, Ph.D., Named V.P. Of Biomarker Development For GeneNews Ltd. Roman L. Zastawny, Ph.D., has been named Vice President of biomarker development for GeneNews Ltd. formerly ChondroGene Ltd.
|
|
Xenon, Takeda strike development deal Xenon Pharmaceuticals Inc. and Takeda Pharmaceutical Company Ltd. entered into an exclusive agreement in October to develop and commercialize oral formulations of Xenon's pain compound, XEN401, in Japan and other Asian countries.
|
|
AnorMed, Poniard amend licensing deal Poniard Pharmaceuticals Inc. is paying AnorMed Inc. US$10 million to amend a licensing agreement allowing the Canadian firm's anti-cancer drug picoplatin to be marketed in Japan.
|
|
Perkin Acquires Avalon Instruments PerkinElmer Inc. has acquired Avalon Instruments Ltd. creating an expanded line of molecular spectroscopy products.
|
|
Millipore, JPT Sign Distribution Pact Millipore Corp. which specializes in tools for kinase research and serves companies targeting kinase biology-based drugs, has struck a distribution and marketing deal with JPT Peptide Technologies GmbH.
|
|
Vasogen Takes FDA To Heart Vasogen Inc. is approaching the US Food and Drug Administration for approval for its heart drug Celcade, following an international trial that showed the product reduced hospitalization time by as much almost one-third.
|
|
VWR To Expand Stratagene In Canadian Market VWR International Inc. has assumed Canadian distribution for Stratagene Corp.
|
|
Axcan Pharma Receives Drug Approval The US Food and Drug Administration has granted approval for Axcan Pharma Inc. to use its drug PyleraTM to treat Helicobacter pylori.
|
|
Queen's University Professor Teams Up With PharmaGap Inc. Pharmacology and Toxicology Professor Michael Adams of Queen's University is to collaborate with PharmaGap Inc. on a drug compound that targets a well known transcription factor expressed by many forms of cancer.
|
|
Liponex Begins A Phase I/II Clinical Trial Liponex Inc. has begun a Phase I/II clinical trial of its compound CRD5.
|
|
Delex Therapeutics Expands Clinical Trial Delex Therapeutics, a division of YM BioSciences Inc. is expanding its Phase IIb clinical trial of the post-surgical pain treatment AeroLEFTM.
|
|
Technology For Art's Sake In the wake of National Research Council's internationally celebrated three-dimensional scanning project on the Mona Lisa, Arius3D Canada Inc. is setting up a dedicated facility in the Louvre to carry out similar work on other historic treasures.
|
|
Enzo Settles One Of Its Lawsuits Neither side is talking about the terms of the deal, but Enzo Biochem Inc. and Sigma-Aldrich Corp. have settled a lawsuit over breach of contract and infringement of patents related to Enzo's proprietary nucleotide technology.
|
|
JEOL celebrates sixth straight success Instrument maker JEOL USA Inc. has again won the Omega Northface Award for exemplary customer service
|
|
S&T Assessed For The Federal Government The recently formed Council of Canadian Academies submitted a survey on Canada's capabilities in science and technology, identifying some areas of research strength even though most observers rank the nation poorly in terms of innovation.
|
|
Researchers Take Quantum Leap The Institute for Quantum Computing at the University of Waterloo has launched a national initiative to create more Canadian researchers at the forefront of fields like quantum cryptography, quantum algorithms and quantum information processing devices.
|
|
Data Management Platform Unleashed Unleashed Informatics, based in Toronto's Mount Sinai Hospital has launched a life science data management platform combining sequence, interaction and related interactome information.
|
|
Promega Drops Suit Against Applied... A lawsuit Promega Corp. launched against Applied Biosystems Group has been dropped, with the companies now expected to negotiate for the rights to patents held by Applied's parent company, Applera and Hoffmann-La Roche Inc.
|
|
Applied teams up with Waters on software Applied Biosystems/MDS SCIEX is to work with Waters Corp. on developing ultra performance liquid chromatography (UPLC), combining the strengths of their respective software platforms to enhance mass spectrometer performance.
|